...
首页> 外文期刊>BMC Cardiovascular Disorders >Chronotherapy for morning blood pressure surge in hypertensive patients: a systematic review and meta-analysis
【24h】

Chronotherapy for morning blood pressure surge in hypertensive patients: a systematic review and meta-analysis

机译:高血压患者早晨血压浪涌的计时疗法:系统评价和荟萃分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The morning blood pressure surge (MBPS) is related to an exaggerated risk of cardiovascular diseases and mortality. With increasing attention on circadian change in blood pressure and extensive use of ambulatory blood pressure monitoring (ABPM), chronotherapy that administration of medication according to biological rhythm, is reported to improve cardiovascular outcomes. The aim of this study is to evaluate the influence of chronotherapy of antihypertensive drugs upon MBPS in hypertensive patients. A search strategy was applied in Ovid MEDLINE, EMBASE, Cochrane (Wiley) CENTRAL Register of Controlled Trials, Cochrane Database of Systematic Reviews, and the Chinese Biomedical literature database. No language and date restrictions. Randomized controlled trials (RCT) assessing the efficacy of evening and morning administration of the same medications in adult patients with primary hypertension were included. A total of ten trials, comprising 1724 participants with a mean age of 61 and 51% female, were included in this study. Combined analysis observed significant reduction of MBPS (??5.30 mmHg, 95% CI ??8.80 to ??1.80), night-time SBP (??2.29 mmHg, 95% CI ??4.43 to ??0.15), night-time DBP (??1.63 mmHg, 95?%CI ??3.23 to ??0.04) and increase in night blood pressure dipping (3.23%, 95% CI 5.37 to 1.10) in evening dosage compared with traditional morning dosage of blood pressure-lowering drugs. No significant difference was found in the incidence of overall adverse effects (RR 0.65, 95% CI 0.30 to 1.41) and withdrawal due to adverse effects (RR 0.95, 95% CI 0.53 to 1.71). Our study suggested that evening administration of antihypertensive medications exerted better blood pressure-lowering effect on MBPS compared with conventional morning dosage. Safety assessment also indicated that the evening regimen did not increase the risk of adverse events. However, endpoint studies need to be carried out to confirm the significance and feasibility of this treatment regimen in clinical practice.
机译:早晨的血压浪涌(Mbps)与夸张的心血管疾病和死亡风险有关。据报道,随着昼夜血压变化和大规模使用动态血压监测(ABPM)的影响,根据生物节律施用药物的计时,以改善心血管结果。本研究的目的是评估高血压患者Mbps对Mbps对抗高血压药物的疗法的影响。搜索策略应用于Ovid Medline,Embase,Cochrane(Wiley)中央控制试验,Cochrane数据库和中国生物医学文献数据库。没有语言和日期限制。分类控制试验(RCT)评估晚上和早上给予同一药物在成人初级高血压患者中的疗效。本研究中纳入了总共有十个有1724名患者的参与者,患有的平均年龄为61和51%的人。综合分析观察到Mbps的显着减少(?? 5.30mmHg,95%CI〜8.80至10.80),夜间SBP(?? 2.29 mmHg,95%CI ?? 4.43到?? 0.15),夜间DBP(?? 1.63 mmHg,95?%CI ?? 3.23至0.04),夜间血压浸渍(3.23%,95%CI 5.37至1.10)与晚间剂量相比,与传统的早晨剂量降低相比药物。在整体不良反应的发生率(RR 0.65,95%CI 0.30至1.41)中没有发现显着差异(RR 0.95,95%CI 0.53至1.71)。我们的研究表明,与常规早晨剂量相比,晚间施用抗高血压药物对Mbps更好的血压降低效果。安全评估还表明,晚期方案没有增加不良事件的风险。然而,需要进行终点研究以确认该治疗方案在临床实践中的重要性和可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号